Sat Feb 4 17:48:30 SGT 2012  
    Beauty TR (Turkey)

Stop Smoking, Turkey

Share |
Summary

Stop Smoking, Turkey @beauty_com_tr: Quit/stop smoking with the medication Champix®. Smoking cessation clinic, Turkey. Private and confidential services. Definitions, references, and latest news.

Description

Quit smoking with the medication Champix®. Revolutionary new way to stop smoking at our smoking cessation clinic. Get away from the harmful effects of smoking, without feeling the effects of withdrawal!

Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic: Stop Smoking, Turkey

References


Latest News

Health Canada's review of the cardiovascular safety of varenicline [Champix] is complete
Thu, 02 Feb 2012 18:34:27 +0100 | Reactions
(Source: Reactions)

Varenicline as a smoking cessation aid in a Greek population: a subanalysis of an observational study
Thu, 02 Feb 2012 05:00:00 +0100 | Tobacco Induced Diseases
Conclusions: In this 'real-world' observational study, 70.4% of Greek smokers successfully quit smoking after 12 weeks of varenicline therapy, providing support that varenicline is an effective smoking cessation medication. Further studies with longer follow-up are warranted.Trial Registration: www.clinicaltrials.gov (unique identifier: NCT00669240). (Source: Tobacco Induced Diseases)

Smoking Cessation Med May Also Help Cocaine DependenceSmoking Cessation Med May Also Help Cocaine Dependence
Thu, 02 Feb 2012 01:18:14 +0100 | Medscape Today Headlines
A small pilot study suggests that varenicline may decrease use and reward effects in patients with cocaine dependence, a condition with no current pharmacologic treatment. Medscape Medical News (Source: Medscape Today Headlines)

FDA review of antismoking aid, varenicline, and neuropsychiatric adverse events.
Wed, 01 Feb 2012 05:00:00 +0100 | The American Journal of Nursing
Authors: Aschenbrenner DS PMID: 22277865 [PubMed - in process] (Source: The American Journal of Nursing)

New Lawsuit filed on Chantix: AttorneyOne.com provides advice and...
Fri, 27 Jan 2012 06:33:34 +0100 | PRWeb: Medical Pharmaceuticals
On Jan. 5th, 2012 Jonathan L. Wince filed the lawsuit No. 8:2012cv00048 in the circuit court for Montgomery Country, Maryland. Jonathan L. Wince accuses Pfizer, the company manufacturing Chantix, for...(PRWeb January 26, 2012)Read the full story at http://www.prweb.com/releases/2012/1/prweb9138855.htm (Source: PRWeb: Medical Pharmaceuticals)

Interventions for preventing weight gain after smoking cessation.
Thu, 26 Jan 2012 08:18:08 +0100 | Cochrane Database of Systematic Reviews
CONCLUSIONS: Although some pharmacotherapies tested to limit PCWG show evidence of short-term success, other problems with them and the lack of data on long-term efficacy limits their use. Weight management education only, is not effective and may reduce abstinence. Personalised weight management support may be effective and not reduce abstinence, but there are too few data to be sure. One study showed a VLCD increased abstinence but did not prevent WG in the longer term. CBT to accept WG did not limit PCWG and may not promote abstinence in the long term. Exercise interventions significantly reduced weight in the long term, but not the short term. More studies are needed to clarify whether this is an effect of treatment or a chance finding. Bupropion, fluoxetine, NRT and varenicline reduce...

Varenicline: Cardiovascular disorders: 27 case reports
Mon, 23 Jan 2012 18:35:21 +0100 | Reactions
(Source: Reactions)

Systematic review of the costâ€effectiveness of varenicline vs. bupropion for smoking cessation
Sat, 21 Jan 2012 13:59:50 +0100 | International Journal of Clinical Practice
Conclusions regarding the costâ€effectives were changed upon sensitivity analysis with the following variables: time horizon, cost of bupropion, efficacy of either drug, age and the incidence of smoking related disease. Varenicline dominated bupropion in most costâ€effectiveness models. However, applicability of models to clinical practice and variables which changed conclusion of costâ€effectiveness should be considered in the interpretation of results. (Source: International Journal of Clinical Practice)

Results of an initial clinical trial of varenicline for the treatment of cocaine dependence
Thu, 19 Jan 2012 17:46:52 +0100 | Drug and Alcohol Dependence
Conclusions: Varenicline appears to decrease cocaine use and reward, suggesting that further investigation of varenicline may be warranted. (Source: Drug and Alcohol Dependence)